DeCART Combining cells with small molecules for better outcomes

Transforming and improving outcomes for cancer patients using drug enhanced CAR T therapies.

CAR-T Therapies illustration
full arrows

Our Science

Enhancing CAR T cells through targeted protein modulation is the scientific foundation of DeCART. Our goal is to modify underlying CAR T biology ex vivo and in vivo through small molecule pharmacologic control of protein levels. Our ultimate goal is to improve CAR T therapies and outcomes for cancer patients.

Protein Icon
Targeted Protein Modulation
T-Cell Icon
CBL-B inhibitors to improve T cell phenotype
CAR-T Cell Icon
Drug enhanced CAR T cell therapies
Scroll to Top